A carregar...
Achieving Neuroprotection with LRRK2 kinase inhibitors in Parkinson Disease
In the translation of discoveries from the laboratory to the clinic, the track record in developing disease-modifying therapies in neurodegenerative disease is poor. A carefully designed development pipeline built from discoveries in both pre-clinical models and patient populations is necessary to o...
Na minha lista:
| Publicado no: | Exp Neurol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693612/ https://ncbi.nlm.nih.gov/pubmed/28764903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2017.07.019 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|